Matches in SemOpenAlex for { <https://semopenalex.org/work/W17029058> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W17029058 endingPage "62" @default.
- W17029058 startingPage "1954" @default.
- W17029058 abstract "To evaluate the antiangiogenic potential of topical ophthalmic formulations of the novel angiostatic steroids AL-3789 and AL-4940, using a rabbit model of corneal neovascularization.Neovascularization was induced in the rabbit cornea by surgical implantation of a standard ethylene vinyl acetate copolymer (Elvax-40) pellet containing 1 microg lipopolysaccharide. Coded formulations of the control vehicle or the following test agents were administered in prevention and intervention treatment protocols: 1% formulations of AL-3789, AL-4940, and cortisol acetate as a positive drug control. Three doses of AL-3789 (0.01%, 0.1%, and 1%) were also evaluated in a prevention treatment protocol. Corneal responses were monitored throughout a 2-week treatment period, and 1 week after the last treatment dose. Observations included quantitative measurement of the area of new blood vessel growth and qualitative assessment of cellular infiltrate and edema. All treatments and observations were performed in a double-masked manner.All tested formulations, except the vehicle and the 0.01% AL-3789 preparation, significantly inhibited corneal neovascularization and other lipopolysaccharide-induced responses in the various treatment protocols employed. AL-4940, the free alcohol form of AL-3789, was slightly less effective than cortisol acetate or AL-3789. The extent of inhibition of the angiogenic response by the 1% and 0.1% AL-3789 suspensions ranged from 76% to 100% 1 week after the last treatment.The antiangiogenic steroid AL-3789 may be a therapeutically useful angiostatic agent for corneal neovascularization and potentially could be effective in other ocular neovascular diseases." @default.
- W17029058 created "2016-06-24" @default.
- W17029058 creator A5004813601 @default.
- W17029058 creator A5011277493 @default.
- W17029058 creator A5024909155 @default.
- W17029058 creator A5036144539 @default.
- W17029058 creator A5089627519 @default.
- W17029058 date "1997-09-01" @default.
- W17029058 modified "2023-10-14" @default.
- W17029058 title "Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization." @default.
- W17029058 cites W16128217 @default.
- W17029058 cites W1965267901 @default.
- W17029058 cites W1974408216 @default.
- W17029058 cites W1984654408 @default.
- W17029058 cites W1997630085 @default.
- W17029058 cites W2002527303 @default.
- W17029058 cites W2008786326 @default.
- W17029058 cites W2018563210 @default.
- W17029058 cites W2020963028 @default.
- W17029058 cites W2035459111 @default.
- W17029058 cites W2044117176 @default.
- W17029058 cites W2052580681 @default.
- W17029058 cites W2053392008 @default.
- W17029058 cites W2055745617 @default.
- W17029058 cites W206434828 @default.
- W17029058 cites W2076907503 @default.
- W17029058 cites W2117258023 @default.
- W17029058 cites W2122902311 @default.
- W17029058 cites W2274037380 @default.
- W17029058 cites W264757739 @default.
- W17029058 cites W611448348 @default.
- W17029058 cites W61674575 @default.
- W17029058 cites W1865624928 @default.
- W17029058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9331259" @default.
- W17029058 hasPublicationYear "1997" @default.
- W17029058 type Work @default.
- W17029058 sameAs 17029058 @default.
- W17029058 citedByCount "32" @default.
- W17029058 countsByYear W170290582012 @default.
- W17029058 countsByYear W170290582015 @default.
- W17029058 countsByYear W170290582022 @default.
- W17029058 crossrefType "journal-article" @default.
- W17029058 hasAuthorship W17029058A5004813601 @default.
- W17029058 hasAuthorship W17029058A5011277493 @default.
- W17029058 hasAuthorship W17029058A5024909155 @default.
- W17029058 hasAuthorship W17029058A5036144539 @default.
- W17029058 hasAuthorship W17029058A5089627519 @default.
- W17029058 hasConcept C118487528 @default.
- W17029058 hasConcept C126322002 @default.
- W17029058 hasConcept C141071460 @default.
- W17029058 hasConcept C2776882836 @default.
- W17029058 hasConcept C2777844972 @default.
- W17029058 hasConcept C2778271429 @default.
- W17029058 hasConcept C2780394083 @default.
- W17029058 hasConcept C71924100 @default.
- W17029058 hasConcept C98274493 @default.
- W17029058 hasConceptScore W17029058C118487528 @default.
- W17029058 hasConceptScore W17029058C126322002 @default.
- W17029058 hasConceptScore W17029058C141071460 @default.
- W17029058 hasConceptScore W17029058C2776882836 @default.
- W17029058 hasConceptScore W17029058C2777844972 @default.
- W17029058 hasConceptScore W17029058C2778271429 @default.
- W17029058 hasConceptScore W17029058C2780394083 @default.
- W17029058 hasConceptScore W17029058C71924100 @default.
- W17029058 hasConceptScore W17029058C98274493 @default.
- W17029058 hasIssue "10" @default.
- W17029058 hasLocation W170290581 @default.
- W17029058 hasOpenAccess W17029058 @default.
- W17029058 hasPrimaryLocation W170290581 @default.
- W17029058 hasRelatedWork W143914307 @default.
- W17029058 hasRelatedWork W2032729680 @default.
- W17029058 hasRelatedWork W2088373629 @default.
- W17029058 hasRelatedWork W2267432055 @default.
- W17029058 hasRelatedWork W2327848465 @default.
- W17029058 hasRelatedWork W2353094037 @default.
- W17029058 hasRelatedWork W2356910019 @default.
- W17029058 hasRelatedWork W2371708501 @default.
- W17029058 hasRelatedWork W2384657291 @default.
- W17029058 hasRelatedWork W2551158016 @default.
- W17029058 hasVolume "38" @default.
- W17029058 isParatext "false" @default.
- W17029058 isRetracted "false" @default.
- W17029058 magId "17029058" @default.
- W17029058 workType "article" @default.